These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 21553105)
1. Carbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 cases. Yang XQ; Chen C; Peng CW; Liu SP; Li Y Med Oncol; 2012 Jun; 29(2):1030-6. PubMed ID: 21553105 [TBL] [Abstract][Full Text] [Related]
2. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer. Yang XQ; Chen C; Wang FB; Peng CW; Li Y Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276 [TBL] [Abstract][Full Text] [Related]
3. Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients. Wang J; Wang X; Yu F; Chen J; Zhao S; Zhang D; Yu Y; Liu X; Tang H; Peng Z Int J Clin Exp Pathol; 2015; 8(11):14853-63. PubMed ID: 26823815 [TBL] [Abstract][Full Text] [Related]
4. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer. Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053 [TBL] [Abstract][Full Text] [Related]
5. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
6. The application of C12 biochip in the diagnosis and monitoring of colorectal cancer: systematic evaluation and suggestion for improvement. Chen C; Chen LQ; Yang GL; Li Y J Postgrad Med; 2008; 54(3):186-90. PubMed ID: 18626164 [TBL] [Abstract][Full Text] [Related]
7. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy. Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876 [TBL] [Abstract][Full Text] [Related]
8. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242. Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125 [TBL] [Abstract][Full Text] [Related]
9. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733 [TBL] [Abstract][Full Text] [Related]
10. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases. Chen C; Chen LQ; Yang GL; Li Y Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322 [TBL] [Abstract][Full Text] [Related]
11. Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer. Dong D; Jia L; Zhang L; Ma N; Zhang A; Zhou Y; Ren L Cancer Sci; 2018 Sep; 109(9):2841-2851. PubMed ID: 29945294 [TBL] [Abstract][Full Text] [Related]
12. [Detection and clinical study of serum tumor markers in patients with colorectal cancer]. Zhao XW; Jiang B; Han CZ; Jing JX Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321 [TBL] [Abstract][Full Text] [Related]
13. Identification of Serum Periostin as a Potential Diagnostic and Prognostic Marker for Colorectal Cancer. Dong D; Zhang L; Jia L; Ji W; Wang Z; Ren L; Niu R; Zhou Y Clin Lab; 2018 Jun; 64(6):973-981. PubMed ID: 29945311 [TBL] [Abstract][Full Text] [Related]
14. [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer]. Zhu YB; Ge SH; Zhang LH; Wang XH; Xing XF; DU H; Hu Y; Li YA; Jia YN; Lin Y; Fan B; Ji JF Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):161-4. PubMed ID: 22368025 [TBL] [Abstract][Full Text] [Related]
15. Tumor markers in staging and prognosis of colorectal carcinoma. Levy M; Visokai V; Lipska L; Topolcan O Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252 [TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. Sun Z; Zhang N World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664 [TBL] [Abstract][Full Text] [Related]
17. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer. Yin LK; Sun XQ; Mou DZ Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189 [TBL] [Abstract][Full Text] [Related]
19. Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study. Dong Q; Yang XH; Zhang Y; Jing W; Zheng LQ; Liu YP; Qu XJ World J Surg Oncol; 2014 Jun; 12():171. PubMed ID: 24890327 [TBL] [Abstract][Full Text] [Related]
20. Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer. Jiang JT; Wu CP; Deng HF; Lu MY; Wu J; Zhang HY; Sun WH; Ji M World J Gastroenterol; 2004 Jun; 10(11):1675-7. PubMed ID: 15162550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]